ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2018. The put-call ratio across all filers is 1.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $0 | -100.0% | 375 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 375 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | -99.2% | 375 | -95.7% | 0.00% | – |
| Q3 2018 | $119,000 | +13.3% | 8,823 | 0.0% | 0.00% | – |
| Q2 2018 | $105,000 | +81.0% | 8,823 | 0.0% | 0.00% | – |
| Q1 2018 | $58,000 | 0.0% | 8,823 | 0.0% | 0.00% | – |
| Q4 2017 | $58,000 | -19.4% | 8,823 | 0.0% | 0.00% | – |
| Q3 2017 | $72,000 | +50.0% | 8,823 | 0.0% | 0.00% | – |
| Q2 2017 | $48,000 | 0.0% | 8,823 | 0.0% | 0.00% | – |
| Q1 2017 | $48,000 | +37.1% | 8,823 | 0.0% | 0.00% | – |
| Q4 2016 | $35,000 | -50.0% | 8,823 | -11.8% | 0.00% | – |
| Q3 2016 | $70,000 | -58.8% | 9,998 | -52.2% | 0.00% | -100.0% |
| Q2 2016 | $170,000 | +580.0% | 20,923 | +574.9% | 0.00% | – |
| Q1 2016 | $25,000 | -32.4% | 3,100 | 0.0% | 0.00% | – |
| Q4 2015 | $37,000 | +27.6% | 3,100 | +24.0% | 0.00% | – |
| Q3 2015 | $29,000 | -12.1% | 2,500 | +37.0% | 0.00% | – |
| Q2 2015 | $33,000 | – | 1,825 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,054,864 | $8,597,000 | 5.88% |
| NEA Management Company, LLC | 9,880,999 | $80,530,000 | 4.18% |
| Abingworth LLP | 250,000 | $2,033,000 | 2.13% |
| New Leaf Venture Partners, L.L.C. | 127,041 | $1,035,000 | 0.89% |
| Iguana Healthcare Management, LLC | 200,000 | $1,630,000 | 0.66% |
| Rock Springs Capital Management LP | 765,001 | $6,235,000 | 0.46% |
| QVT Financial LP | 783,645 | $6,387,000 | 0.44% |
| Opaleye Management Inc. | 40,000 | $326,000 | 0.22% |
| Rathbones Group PLC | 450,525 | $3,672,000 | 0.20% |
| Virtus ETF Advisers LLC | 26,974 | $220,000 | 0.16% |